Close Menu
  • Home
  • Vaccines
  • Politics
  • Health
  • Tech
  • Sports
  • Research
  • Fitness
  • Careers
What's Hot

Health Canada approves Novartis’ KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence

Sheriff, county lawyer seeking mental health funds at Minnesota State Capitol

Chronic absences have not disappeared. Research shows that poor children are most hurt.

Facebook X (Twitter) Instagram
subjectional.com
Subscribe
  • Home
  • Vaccines
  • Politics
  • Health
  • Tech
  • Sports
  • Research
  • Fitness
  • Careers
subjectional.com
Home » CDC lowers recommended age for pneumococcal vaccine from 65 to 50: NPR
Vaccines

CDC lowers recommended age for pneumococcal vaccine from 65 to 50: NPR

Paul E.By Paul E.October 24, 2024No Comments3 Mins Read
Share Facebook Twitter Pinterest Copy Link Telegram LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email


This electron microscopy image provided by the Centers for Disease Control and Prevention shows two round-shaped Gram-positive Streptococcus pneumoniae bacteria. Hide AP/CDC Caption

Toggle caption AP/CDC

For the first time, the U.S. Centers for Disease Control and Prevention has lowered the recommended age for pneumococcal vaccination from 65 to 50.

“Lowering the age range for pneumococcal vaccination will give more adults the opportunity to protect themselves from pneumococcal disease at an age when their risk of infection significantly increases,” the CDC said in a statement.

“Pneumococci can cause serious illnesses such as pneumonia, meningitis, and bloodstream infections, and older adults are at higher risk of pneumococcal disease.”

Wednesday’s advisory comes as respiratory infections caused by the bacterium Mycoplasma pneumoniae are on the rise across the United States, especially in children, according to the CDC. This marks a change from previous years, when most cases involved older children and adolescents.

This year, the number of people diagnosed with the bacteria that causes pneumonia, or bronchitis, has increased over the past six months and peaked in August, authorities said.

Mycoplasma pneumonia causes respiratory infections such as pneumonia and can be spread as droplets through sneezing or coughing. Symptoms vary depending on the type of infection, but some common symptoms include fatigue, fever, and cough, according to the CDC. Children under 5 years of age may have diarrhea, runny nose, and vomiting.

Some people may be infected but have no symptoms. People with pneumonia who do not require bed rest or hospital treatment may have a milder form of the infection known as “walking pneumonia.” A person may develop pneumonia more than once.

Approximately 2 million infections due to Mycoplasma pneumonia are diagnosed each year, although the actual number is likely much higher.

Treatment for pneumonia may include antibiotics, and some people recover without drugs, according to the CDC. There are currently two vaccines available in the United States to prevent pneumonia. There are four vaccines in the United States that target 15 or more pneumococcal strains.

The CDC’s Advisory Committee on Immunization Practices also announced Wednesday that people age 65 and older who are moderately or severely immunocompromised should be given an additional, up-to-date COVID-19 booster shot six months after their first booster shot. Voted in favor of recommending therapy.

“This vote allows people to make the best decisions possible to protect themselves and their loved ones from COVID-19,” CDC Director Dr. Mandy Cohen said in a statement. “CDC continues to educate the public about how and when to get the latest vaccinations to reduce their risk of serious illness and help them do more of the things they love.”

The number of coronavirus infections is decreasing across the United States, according to data from the CDC.



Source link

Follow on Google News Follow on Flipboard
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Copy Link
Previous ArticleThree stories from Saturday’s game against Georgia Tech.
Next Article WHO Foundation and Maybelline New York partner to support global mental health efforts
Paul E.
  • Website

Related Posts

Kentucky leaders emphasize whooping cough vaccination

October 31, 2024

Safety, efficacy and immunogenicity of aerosolized Ad5-nCoV COVID-19 vaccine in a non-inferiority randomized controlled trial

October 31, 2024

Trust is important, but increasing vaccination rates also requires three things

October 31, 2024
Leave A Reply Cancel Reply

Latest Posts

Health Canada approves Novartis’ KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence

Sheriff, county lawyer seeking mental health funds at Minnesota State Capitol

Chronic absences have not disappeared. Research shows that poor children are most hurt.

Transport Secretary reveals overhaul of aging pneumatic transport systems

Latest Posts

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Welcome to Subjectional!

At Subjectional, we believe that informed opinions are the foundation of a vibrant society. Our mission is to provide insightful, engaging, and balanced information across a diverse range of topics that matter to you. Whether you’re interested in the latest developments in health, navigating the complexities of politics, staying updated on sports, exploring technological advancements, or advancing your career, we’ve got you covered.

Facebook X (Twitter) Instagram Pinterest YouTube

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Facebook X (Twitter) Instagram Pinterest
  • Home
  • About Us
  • Advertise with Us
  • Contact us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
© 2025 subjectional. Designed by subjectional.

Type above and press Enter to search. Press Esc to cancel.